Latest News in the pharma Industry

All

Bayer submits BLA in the for BAY94-9027 – a long-acting factor VIII for the treatment of hemophilia A

Bayer submits BLA in the for BAY94-9027 – a long-acting factor VIII for the treatment of hemophilia A

3 Sep 2017

Pivotal studies with BAY94-9027 showed that bleed protection was achieved with extended dosing intervals.

Read more 
Merck successfully closes biosimilars transaction

Merck successfully closes biosimilars transaction

1 Sep 2017

Step towards strategic alignment of R&D resources to Healthcare priorities.

Read more 
FDA approves Pfizer's Mylotarg for treatment of AML

FDA approves Pfizer's Mylotarg for treatment of AML

1 Sep 2017

Only approved antibody-drug conjugate for newly diagnosed and relapsed or refractory CD33-positive AML.

Read more 
Xeno-free cell culture medium for regenerative medicine research

Xeno-free cell culture medium for regenerative medicine research

31 Aug 2017

StemFit Basic02 offers superior and stable growth performance, high colony forming efficiency and robust scalable cell expansion.

Read more 
Thermo Fisher Scientific completes acquisition of Patheon

Thermo Fisher Scientific completes acquisition of Patheon

31 Aug 2017

Patheon's CDMO capabilities coupled with Thermo's clinical trials services and bioproduction technologies expected to make Thermo and "even stronger partner" for its pharmaceutical and biotech customers.

Read more 
AstraZeneca and Takeda collaborate to develop and commercialise MEDI1341 for Parkinson’s disease

AstraZeneca and Takeda collaborate to develop and commercialise MEDI1341 for Parkinson’s disease

31 Aug 2017

MEDI1341 has the potential to achieve a better efficacy and safety profile than other alpha-synuclein antibodies.

Read more 
Phase III study confirms Kyprolis regimen extends overall survival In patients with relapsed multiple myeloma

Phase III study confirms Kyprolis regimen extends overall survival In patients with relapsed multiple myeloma

31 Aug 2017

ENDEAVOR study long-term data show Kyprolis and dexamethasone reduced the risk of death by 24% versus Velcade and dexamethasone.

Read more 
Cambrex invests in new analytical development and method validation laboratory at its High Point, NC Facility

Cambrex invests in new analytical development and method validation laboratory at its High Point, NC Facility

30 Aug 2017

Expansion comes as a result of increased industry demand to better understand and characterize APIs and process intermediates at the clinical stage.

Read more 
Lilly to file baricitinib resubmission to FDA before end of January 2018

Lilly to file baricitinib resubmission to FDA before end of January 2018

30 Aug 2017

Resubmission package will include new safety and efficacy data.

Read more 
Novartis receives first ever FDA approval for a CAR-T cell therapy

Novartis receives first ever FDA approval for a CAR-T cell therapy

30 Aug 2017

Kymriah approvaed for children and young adults with B-cell ALL that is refractory or has relapsed at least twice.

Read more 
FDA approves new antibacterial drug

FDA approves new antibacterial drug

30 Aug 2017

First carbapenem-based combination product – combination of meropenem with a new class of beta-lactamase inhibitor.

Read more 
Fire at Ashland facility suspends production of BDO, THF and formaldehyde

Fire at Ashland facility suspends production of BDO, THF and formaldehyde

29 Aug 2017

Volume expected to remain somewhat constrained into the first quarter of fiscal 2018.

Read more